Showing results (401-410 of 419) with videos related to

Sort By:
Pageof 42
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 3, 2022
Synchronized, Spontaneous, and Oscillatory Detachment of Eukaryotic Cells: A New Tool for Cell Characterization and IdentificationDerick Yongabi, Mehran Khorshid, Patricia Losada-Pérez, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Anilinotriazoles as potent gamma secretase modulatorsAdriana I Velter, François P Bischoff, Didier Berthelot, et al.
Stroke|April 3, 2025
Topographic Localization of Chronic Cerebellar Ischemic Lesions: Implications for Underlying CauseMarkus Kneihsl, Arsany Hakim, Martina B Goeldlin, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2016
Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancerMariëtte I E van Poelgeest, Valeria V Visconti, Zohara Aghai, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 15, 2025
Ultrafast Light-Driven Electronic and Structural Changes in LaFeO<sub>3</sub> Perovskites Probed by Femtosecond X-Ray Absorption SpectroscopyMasoud Lazemi, Fabian J Mohammad, Sang Han Park, et al.
Nature|June 29, 2016
Neoantigen landscape dynamics during human melanoma-T cell interactionsEls M E Verdegaal, Noel F C C de Miranda, Marten Visser, et al.
Nature Immunology|November 1, 2022
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responsesThomas Hagan, Bram Gerritsen, Lewis E Tomalin, et al.
Archives of Toxicology|January 25, 2018
Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigmsChris S Pridgeon, Constanze Schlott, Min Wei Wong, et al.
Neurology|August 29, 2025
Small Vessel Disease Phenotype Associated With Monoallelic <i>NOTCH3</i> Loss-of-Function VariantsJosephine S van Asbeck, Gido Gravesteijn, Minne N Cerfontaine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2025
Effective TIL therapy for patients with checkpoint-resistant melanoma without lymphodepleting regimens requires interferon-alphaEls M E Verdegaal, Anique L C Verpoorte, Monique K van der Kooij, et al.
Pageof 42